A phase I clinical trial on intratumoral injection of autologous CD1c (BDCA-1)+ / CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec (T-VEC) in patients with advanced pretreated melanoma
- Schwarze, J. K. (Presenter)
- Jens Tijtgat (Contributor)
- Awada, G. (Contributor)
- Louise Cras (Contributor)
- Dufait, I. (Contributor)
- Forsyth, R. (Contributor)
- Tuyaerts, S. (Contributor)
- Neyns, B. (Contributor)
Activity: Talk or presentation › Talk or presentation at a conference